Lipoprotein(a): A Genetically Determined, Causal, and Prevalent
Por um escritor misterioso
Descrição
Clinical Trial Design for Lipoprotein(a)-Lowering Therapies: JACC Focus Seminar 2/3 - ScienceDirect
Lipoprotein(a): A Genetically Determined, Causal, and Prevalent Risk Factor for Atherosclerotic Cardiovascular Disease - Professional Heart Daily
IJMS, Free Full-Text
Clinical Feature: The ABCs of Lipoprotein(a)
Small Interfering RNA to Reduce Lipoprotein(a) in Cardiovascular Disease
Frontiers Familial Hypercholesterolemia and Elevated Lipoprotein(a): Cascade Testing and Other Implications for Contextual Models of Care
Nutrients, Free Full-Text
Lipoprotein(a) and Cardiovascular Disease in Chinese Population: A Beijing Heart Society Expert Scientific Statement
Molecules, Free Full-Text
Genome-Wide Association Study Highlights APOH as a Novel Locus for Lipoprotein(a) Levels—Brief Report
Lipoprotein(a) and Family History Predict Cardiovascular Disease Risk
LPA disruption with AAV-CRISPR potently lowers plasma apo(a) in transgenic mouse model: A proof-of-concept study: Molecular Therapy - Methods & Clinical Development
8 Things to Know About Lipoprotein(a)
Non-genetic influences on lipoprotein(a) concentrations - ScienceDirect
-T1.gif)
Lipoprotein(a) and Cardiovascular Risk
